ADIPOQ and type 2 diabetes mellitus: Consistent with these findings, further research indicates that the clinical manifestations of LADY lie between those of T1DM and T2DM: BMI and hs-CRP progressively increase from T1DM to LADY to T2DM, while adiponectin progressively decreases (75).